UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Pharmacological activation of the hERG K+ channel for the management of the long QT syndrome: A review

Journal of arrhythmia, 2022-08, Vol.38 (4), p.554-569

2022

Link zum Volltext

Verfügbarkeit prüfen

Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria

PLoS computational biology, 2017-06, Vol.13 (6), p.e1005593-e1005593

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2

Frontiers in cardiovascular medicine, 2020-05, Vol.7, p.85-85

2020

Link zum Volltext

Verfügbarkeit prüfen

Structural implications of hERG K+ channel block by a high-affinity minimally structured blocker

The Journal of biological chemistry, 2018-05, Vol.293 (18), p.7040-7057

2018

Link zum Volltext

Verfügbarkeit prüfen

Modification of KCNH2-Encoded Cardiac Potassium Channels by KCNE1 Polymorphism

Circulation Journal, 2014/08/25, Vol.78(9), pp.2330

2014

Link zum Volltext

Verfügbarkeit prüfen

Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition

Physiological reports, 2013-11, Vol.1 (6), p.e00175-n/a

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue

Pharmaceuticals (Basel, Switzerland), 2023-08, Vol.16 (9), p.1204

2023

Link zum Volltext

Verfügbarkeit prüfen

In silico investigation of a KCNQ1 mutation associated with short QT syndrome

Scientific reports, 2017-08, Vol.7 (1), p.8469-14, Article 8469

2017

Link zum Volltext

Verfügbarkeit prüfen

hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine

Journal of the American Heart Association, 2015-04, Vol.4 (4)

2015

Link zum Volltext

Verfügbarkeit prüfen

Investigation of hERG1b influence on hERG channel pharmacology at physiological temperature

Journal of pharmacology & pharmacotherapeutics, 2018-04, Vol.9 (2), p.92-103

2018

Link zum Volltext

Verfügbarkeit prüfen

Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel

PloS one, 2012-12, Vol.7 (12), p.e52451

2012

Link zum Volltext

Verfügbarkeit prüfen

The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine

Physiological reports, 2020-03, Vol.8 (5), p.e14385-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration

Physiological reports, 2014-10, Vol.2 (10), p.e12165-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction

Journal of pharmacological and toxicological methods, 2023-09, Vol.123, p.107293-107293, Article 107293

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel genetic modifier for clarithromycin-related cardiac arrhythmia risk?

Therapeutic advances in infectious disease, 2014-04, Vol.2 (2), p.71-72

2014

Link zum Volltext

Verfügbarkeit prüfen

The hERG potassium channel and hERG screening for drug-induced torsades de pointes

Pharmacology & therapeutics (Oxford), 2008-08, Vol.119 (2), p.118-132

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide

Journal of molecular and cellular cardiology, 2015-09, Vol.86, p.42-53

2015

Link zum Volltext

Verfügbarkeit prüfen

Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants

Journal of molecular and cellular cardiology, 2014-09, Vol.74 (100), p.220-230

2014

Link zum Volltext

Verfügbarkeit prüfen

Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling

Cardiovascular research, 2012-04, Vol.94 (1), p.66-76

2012

Link zum Volltext

Verfügbarkeit prüfen

Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking

Biochemical pharmacology, 2016-08, Vol.113, p.24-35

2016

Link zum Volltext

Verfügbarkeit prüfen

Investigation of the Influence of hERG 1b on hERG Channel Pharmacology

Biophysical journal, 2013-01, Vol.104 (2), p.297a-297a

2013

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of Flecainide Inhibition of hERG Channels to Channel Inactivation

Biophysical journal, 2014-01, Vol.106 (2), p.138a-138a

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular determinants of hERG potassium channel inhibition by disopyramide

Journal of molecular and cellular cardiology, 2012-01, Vol.52 (1), p.185-195

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity

Cardiovascular research, 2005, Vol.65 (1), p.128-137

2005

Link zum Volltext

Verfügbarkeit prüfen

Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome

Journal of molecular and cellular cardiology, 2009-11, Vol.47 (5), p.743-747

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(42)
Buchkapitel
(2)

Sprache

Englisch
(44)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(18)
Mutation
(15)
Cardiac & Cardiovascular Systems
(14)
Cardiovascular System & Cardiology
(14)
Animals
(13)
Patch-Clamp Techniques
(13)
Herg
(12)
Arrhythmia
(11)
Qt Interval
(9)
Hek293 Cells
(8)
Potassium Channels
(8)
Male
(7)
Action Potential
(6)
Action Potentials
(6)
Anti-Arrhythmia Agents - Pharmacology
(6)
Cardiovascular
(6)
Cell Biology
(6)
Dose-Response Relationship, Drug
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacological activation of the hERG K+ channel for the management of the long QT syndrome: A review

Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria

COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2

Structural implications of hERG K+ channel block by a high-affinity minimally structured blocker

Modification of KCNH2-Encoded Cardiac Potassium Channels by KCNE1 Polymorphism

Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition

Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue

In silico investigation of a KCNQ1 mutation associated with short QT syndrome

hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine

Investigation of hERG1b influence on hERG channel pharmacology at physiological temperature

Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel

The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine

Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration

hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction

A novel genetic modifier for clarithromycin-related cardiac arrhythmia risk?

The hERG potassium channel and hERG screening for drug-induced torsades de pointes

Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide

Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants

Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling

Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking

Investigation of the Influence of hERG 1b on hERG Channel Pharmacology

Sensitivity of Flecainide Inhibition of hERG Channels to Channel Inactivation

Molecular determinants of hERG potassium channel inhibition by disopyramide

Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity

Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome

Suchergebnisse filtern